SCINAI IMMUNOTHERAPEUTICS LTD. Increase Decrease Through Changes In Fair Values Liabilities Arising From Financing Activities
SCINAI IMMUNOTHERAPEUTICS LTD. (SCNI) reported Increase Decrease Through Changes In Fair Values Liabilities Arising From Financing Activities of -ILS 2.83 million for the 12-month period ending 2021-12-31, per its 20-F filed 2022-03-28.
Discontinued › Cash Flow › Operating Activities
ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities · last filed 2022-03-28
- SCINAI IMMUNOTHERAPEUTICS LTD. increase decrease through changes in fair values liabilities arising from financing activities for the quarter ending 2020-12-31 was 127.90M ILS, a 142007.78% increase year-over-year.
- SCINAI IMMUNOTHERAPEUTICS LTD. increase decrease through changes in fair values liabilities arising from financing activities for the quarter ending 2020-09-30 was -62.80M ILS.
- SCINAI IMMUNOTHERAPEUTICS LTD. increase decrease through changes in fair values liabilities arising from financing activities for the quarter ending 2019-12-31 was 90.00K ILS.
- SCINAI IMMUNOTHERAPEUTICS LTD. increase decrease through changes in fair values liabilities arising from financing activities for the quarter ending 2019-09-30 was -2.62M ILS.
| Period end | Increase Decrease Through Changes In Fair Values Liabilities Arising From Financing Activities 3 month | Increase Decrease Through Changes In Fair Values Liabilities Arising From Financing Activities 6 month | Increase Decrease Through Changes In Fair Values Liabilities Arising From Financing Activities 9 month | Increase Decrease Through Changes In Fair Values Liabilities Arising From Financing Activities 12 month | Increase Decrease Through Changes In Fair Values Liabilities Arising From Financing Activities 12 month as first filed |
|---|---|---|---|---|---|
| 2021-12-31 | -2.83M ILS 20-F · filed 2022-03-28 | ||||
| 2020-12-31 | 127.90M ILS derived: 20-F 12 month − 6-K 9 month · filed 2022-03-28 | 65.10M ILS derived: sum of 2 quarters · filed 2022-03-28 | 63.36M ILS 20-F · filed 2022-03-28 | -63.36M ILS 20-F · filed 2021-05-13 | |
| 2020-09-30 | -62.80M ILS derived: 6-K 9 month − 6-K 6 month · filed 2021-01-28 | -64.54M ILS 6-K · filed 2021-01-28 | |||
| 2020-06-30 | -1.74M ILS 6-K · filed 2020-10-02 | ||||
| 2019-12-31 | 90.00K ILS derived: 20-F 12 month − 6-K 9 month · filed 2021-05-13 | -2.53M ILS derived: sum of 2 quarters · filed 2021-05-13 | 14.08M ILS 20-F · filed 2021-05-13 | ||
| 2019-09-30 | -2.62M ILS derived: 6-K 9 month − 6-K 6 month · filed 2021-01-28 | 13.99M ILS 6-K · filed 2021-01-28 | |||
| 2019-06-30 | 16.61M ILS 6-K · filed 2020-10-02 | ||||
| 2018-12-31 | 10.04M ILS 20-F · filed 2020-06-12 |